Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Luca De Carolis"'
Autor:
Gianni Celli, Giuditta Pisano, Simona Ruggeri, Gian Giuseppe Soma, Fabrizio Pilo, Carlo Papa, Claudio Pregagnoli, Luca de Carolis, Simone Ferrero, Fabio Cazzato
Publikováno v:
IEEE Access, Vol 12, Pp 92227-92240 (2024)
Reaching the European climate target is a complex and multifaceted challenge that involves different sectors and requires coordinated efforts at various levels. Increasing the share of renewable energy sources in the energy mix and the electrificatio
Externí odkaz:
https://doaj.org/article/2b6ed6d7e8784a129fd41bceb0e66bd5
Autor:
Enrico Tiacci, Alessandro Mancini, Monia Marchetti, Gianna Maria D'Elia, Anna Candoni, Alessandro Morotti, Alessandra Romano, Alessandro Gozzetti, Alessandro Broccoli, Luca De Carolis, Riccardo Bruna, Maria Chiara Tisi, Carmine Selleri, Monia Capponi, Daniele Vallisa, Chiara Cattaneo, Matteo Giovanni Della Porta, Alessandro Busca, Brunangelo Falini, Massimo Massaia, Lorenza Bertù, Alessandro Pulsoni, Paolo Rivela, Paolo Corradini, Francesco Passamonti
Publikováno v:
British Journal of Haematology. 201:411-416
Little is known of the course of COVID-19 and the antibody response to infection or vaccination in patients with hairy-cell leukaemia (HCL). Among a total of 58 HCL cases we studied in these regards, 37 unvaccinated patients, mostly enjoying a relati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::166cf878c4eee315de39deb787af4b13
https://doi.org/10.1111/bjh.18606
https://doi.org/10.1111/bjh.18606
Autor:
Alessio Cerquaglia, Marco Lupidi, Jay Chhablani, Ramkailash Gujar, Barbara Iaccheri, Tito Fiore, Daniela Fruttini, Antonello Ramundo, Kiran Kumar Vupparaboina, Luca Castellani, Edoardo Simonetti, Luca De Carolis, Enrico Tiacci, Brunangelo Falini, Carlo Cagini
Purpose To evaluate choroidal vascularity index (CVI) in patients developing mitogen-activated protein kinase kinase (MEK) inhibitor-associated retinopathy (MEKAR). Methods In this prospective observational study, extensive ophthalmic examination was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15b768da4ec807d0e0aa2959379de2a1
https://hdl.handle.net/11391/1505386
https://hdl.handle.net/11391/1505386
Autor:
Samantha Ferrari, L. Rigacci, Monia Capponi, Alessandro Pulsoni, Giuseppe Visani, Luca De Carolis, Pier Luigi Zinzani, Robin Foà, Paolo Falcucci, Enrico Tiacci, G. Gaidano, Eugenio Lucia, Agostino Antolino, Francesco Zaja, A. Ambrosetti, Stefano Ascani, Roberta Della Seta, Edoardo Simonetti, Natalia Frattarelli, Vincenzo Perriello, Brunangelo Falini
Publikováno v:
The New England journal of medicine. 384(19)
Hairy-cell leukemia (HCL) is a CD20+ indolent B-cell cancer in which a BRAF V600E kinase-activating mutation plays a pathogenetic role. In clinical trials involving patients with refractory or relapsed HCL, the targeting of BRAF V600E with the oral B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::581643bba7c5ece8a9566c9341192e78
https://pubmed.ncbi.nlm.nih.gov/34031574
https://pubmed.ncbi.nlm.nih.gov/34031574
Autor:
Valentina Pettirossi, Alessandra Pucciarini, Enrico Tiacci, Stefano Volpetti, Alessia Santi, Mara Merluzzi, Vincenzo Perriello, Alessandra Venanzi, Edoardo Simonetti, Antonio Bennati, Brunangelo Falini, Gianluca Schiavoni, Stefano Ascani, Luca De Carolis, Luisa Tasselli
Publikováno v:
Leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc552a772c5c146306357086af3b3837
https://pubmed.ncbi.nlm.nih.gov/33731847
https://pubmed.ncbi.nlm.nih.gov/33731847
Autor:
Daniel Oruzio, Marco Sborgia, Giorgina Specchia, Susanne Schnittger, Torsten Haferlach, Karl-Anton Kreuzer, Rudolf Peceny, Antony B. Holmes, Raul Rabadan, Hubert Serve, Joseph M. Chan, Victoria A. Wells, Sonja Schindela, Katharina Goetze, Orietta Spinelli, Luca De Carolis, Laurent Farinelli, Roberta Rossi, Alessandro Rambaldi, Martin Dugas, Renato Bassan, Ariele Spanhol-Rosseto, Arcangelo Liso, Stefano Baldoni, Francesco Fabbiano, Laura Pasqualucci, Claudia Haferlach, Alexander Kohlmann, Francesco Di Raimondo, Wolfgang Kern, Vera Grossmann, Maria Paola Martelli, Vladimir Trifonov, Enrico Tiacci, Brunangelo Falini, Hans-Ulrich Klein
Among acute myeloid leukemia (AML) patients with a normal karyotype (CN-AML), NPM1 and CEBPA mutations define World Health Organization 2008 provisional entities accounting for approximately 60% of patients, but the remaining 40% are molecularly poor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52b5a600e60f54b0b45076181958b29e
http://hdl.handle.net/11697/124319
http://hdl.handle.net/11697/124319
Autor:
Marica Gemei, Roberta Pacini, Uta Oelschlägel, Raffaella Ciurnelli, Luca De Carolis, Massimo F. Martelli, Valentina Pettirossi, Alessia Tabarrini, Federica Mezzasoma, Roberta Rossi, Arcangelo Liso, Maria Paola Martelli, Elisabetta Bonifacio, Debora Cecchini, Linda Giunchi, Christian Thiede, Federica Cecchetti, Lorenzo Brunetti, Mauro Di Ianni, Ilaria Gionfriddo, Francesco Di Raimondo, Brunangelo Falini
Publikováno v:
Publons
Abstract 480 Acute myeloid leukemia with mutated NPM1 gene and cytoplasmic nucleophosmin (NPMc+ AML) [Falini B et al, NEJM 2005;352:254-266] is a new entity of WHO classification that shows distinctive biological and clinical features [Falini B et al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f5f433fe685139134150ca8e6f42d97
http://hdl.handle.net/20.500.11769/75880
http://hdl.handle.net/20.500.11769/75880
Autor:
Davide Rossi, Michele Cimminiello, Alessandro Pulsoni, Antonella Anastasia, Luca De Carolis, Stefano Pileri, Marzia Varettoni, Pier Luigi Zinzani, Pietro Leoni, Achille Ambrosetti, Angelo Michele Carella, Giovanna Motta, Enrico Tiacci, Brunangelo Falini, Francesco Zaja, Alessandro Rambaldi, Robin Foà, Vincenzo Fraticelli
Publikováno v:
Blood. 124:150-150
BACKGROUND AND AIMS: Hairy cell leukemia (HCL) is very sensitive to purine analogs (PAs), but ~40% of patients relapse and become progressively less responsive to these myelotoxic and immune-suppressive drugs. Having discovered the BRAF-V600E kinase-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cecd6650a2861accbc9e496d47e48397
https://doi.org/10.1182/blood.v124.21.150.150
https://doi.org/10.1182/blood.v124.21.150.150